Skip to main content

Dr. Sameem M. Abedin, MD

Hematology & Oncology (Hematology & Oncology Physician)

9200 W Wisconsin Ave
Milwaukee, WI 53226

Who else practices at this address →

Milwaukee County includes primary care (32% of residents) and mental health (34% of residents) shortage areas. About shortage areas

Call (414) 805-4600

  • Medicare participating

At a glance

Years since graduation
17
In the NPI registry since
2009
Medicare patients seen, 2024
123

Licensed in Illinois since 2014, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2009Medical school: Jefferson Medical College of Thomas Jefferson University
  • 2009Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    WI license 67714
  • Internal Medicine Physician
    IL license 036135124 (first issued 2014; not renewed) · MI license 4301100128 · PA license MT195216

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
123
Services billed
681
Patients’ average age
70
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes12441
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes9629
Established patient office or other outpatient visit, 20-29 minutes9038
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes7628
Established patient office or other outpatient visit, 40-54 minutes6825

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 6 companies reported 28 payments worth $28,301 in total to this clinician.

By company
Incyte Corporation$16,669
Genzyme Corporation$10,470
Daiichi Sankyo Inc.$650
National Marrow Donor Program$325
Medexus Pharma, Inc.$169
AbbVie Inc.$17.45
By type
Consulting Fee$23,944
Travel and Lodging$3,277
Food and Beverage$1,080

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jun 14, 2025Genzyme Corporation
Jun 14, 2025
Consulting Fee$9,251
Dec 1, 2025Incyte Corporation
Dec 1, 2025
Consulting Fee$7,193
May 8, 2025Incyte Corporation
May 8, 2025
Consulting Fee
Niktimvo · Oncology
$6,850
Oct 8, 2025Incyte Corporation
Oct 8, 2025
Travel and Lodging
travel to Minneapolis, MN
$897
Apr 10, 2025Daiichi Sankyo Inc.
Apr 10, 2025
Consulting Fee
Vanflyta · ONCOLOGY
$650
Jun 7, 2025Genzyme Corporation
Jun 7, 2025
Travel and Lodging
travel to San Francisco, CA · in-kind
$545
Apr 24, 2025Incyte Corporation
Apr 24, 2025
Travel and Lodging
Niktimvo · Oncology · travel to Denver, CO
$531
Jun 7, 2025Genzyme Corporation
Jun 7, 2025
Travel and Lodging
travel to San Francisco, CA · in-kind
$330
Apr 25, 2025Incyte Corporation
Apr 25, 2025
Travel and Lodging
Niktimvo · Oncology · travel to Denver, CO
$291
Oct 14, 2025Incyte Corporation
Oct 14, 2025
Travel and Lodging
travel to Minneapolis, MN
$231
All 15 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 1, 2025Incyte Corporation
Dec 1, 2025
Consulting Fee$7,193
Oct 15, 2025Incyte Corporation
Oct 15, 2025
Travel and Lodging
travel to Minneapolis, MN
$150
Oct 14, 2025Incyte Corporation
Oct 14, 2025
Travel and Lodging
travel to Minneapolis, MN
$231
Oct 14, 2025Incyte Corporation
Oct 14, 2025
Travel and Lodging
travel to Minneapolis, MN
$209
Oct 8, 2025Incyte Corporation
Oct 8, 2025
Travel and Lodging
travel to Minneapolis, MN
$897
Jun 14, 2025Genzyme Corporation
Jun 14, 2025
Consulting Fee$9,251
Jun 14, 2025Genzyme Corporation
Jun 14, 2025
Travel and Lodging
travel to San Francisco, CA
$54.00
Jun 7, 2025Genzyme Corporation
Jun 7, 2025
Travel and Lodging
travel to San Francisco, CA · in-kind
$545
Jun 7, 2025Genzyme Corporation
Jun 7, 2025
Travel and Lodging
travel to San Francisco, CA · in-kind
$330
May 8, 2025Incyte Corporation
May 8, 2025
Consulting Fee
Niktimvo · Oncology
$6,850
Apr 25, 2025Incyte Corporation
Apr 25, 2025
Travel and Lodging
Niktimvo · Oncology · travel to Denver, CO
$291
Apr 25, 2025Incyte Corporation
Apr 25, 2025
Travel and Lodging
Niktimvo · Oncology · travel to Denver, CO
$22.40
Apr 25, 2025Incyte Corporation
Apr 25, 2025
Travel and Lodging
Niktimvo · Oncology · travel to Denver, CO
$18.00
Apr 24, 2025Incyte Corporation
Apr 24, 2025
Travel and Lodging
Niktimvo · Oncology · travel to Denver, CO
$531
Apr 10, 2025Daiichi Sankyo Inc.
Apr 10, 2025
Consulting Fee
Vanflyta · ONCOLOGY
$650

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Wisconsin →

Industry-funded research

Named as a principal investigator on 7 industry-funded studies in 2025, from 5 companies. The companies reported $414,011 in research payments for these studies, mostly to the institutions running them.

  • A Phase II Trial of De-escalated PTCy and Ruxolitinib for GVHD Prophylaxis in Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT
    Incyte Corporation
  • A Phase II Study of Reduced Dose Post Transplantation Cyclophosphamide as GvHD Prophylaxis in Adult Patients with Hematologic Malignancies Receiving HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplant…
    National Marrow Donor Program
  • A First in Human Study of the MeninKMT2A MLL1 Inhibitor JNJ75276617 in Participants with Acute Leukemia
    Janssen Research & Development, LLC
  • AUTO1-AL1
    Autolus Inc
  • A Phase 1/2, Multicenter, Open-Label, Randomized Dose Ranging and Expansion Study of the Combination of Gilteritinib, Venetoclax and Azacitidine in Patients With Newly Diagnosed FLT3 Mutated Acute Myeloid Leukemia (AM…
    Astellas Pharma Global Development
  • A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate/Ruxolitinib versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic…
    National Marrow Donor Program
  • Facilitating Activation of Study Trials (FAST)
    National Marrow Donor Program

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hematology & Oncology clinicians in Milwaukee

Sources

NPI registry (CMS NPPES, November 2026; record last updated July 21, 2022), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1063641157. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.